Changes in the size of target lesions over time are shown in Fig. 1A; tumor reductions at nadir were observed irrespective of PD-L1 expression, including in patients with a PD-L1 combined positive score of 0 (Fig. 1B). The gene discussed is CD274; the disease is neoplasm.